good points Zedcopr, and accords with the company's announced...

good points Zedcopr, and accords with the company's announced strategy back on 5th March. In that announcement, they say "
Patients recruited for this trial will be screened to confirm eligibility
during a 28 day period after which dosing will commence. Some
patients may also need to “washout” any current acromegaly medications
for a period of 6 weeks to 4 months, depending on
the type of medication, before dosing with ATL1103
can begin. "

If I was a patient on the lower dose I'd be grumpy and fearful of such a long period of not being on my medication; I wonder how the company handles that sort of thing to convince the participants that it is a good thing.